A share price of Privia Health Group Inc [PRVA] is currently trading at $17.97, up 1.35%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRVA shares have gain 1.93% over the last week, with a monthly amount drifted -1.32%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Privia Health Group Inc [NASDAQ: PRVA] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $23. Previously, Robert W. Baird started tracking the stock with Outperform rating on May 30, 2024, and set its price target to $23. On April 22, 2024, Citigroup initiated with a Buy rating and assigned a price target of $25 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $22 on March 06, 2024. BofA Securities downgraded its rating to Neutral for this stock on February 22, 2024, but kept the price target unchanged to $21. In a note dated December 06, 2023, JMP Securities initiated an Mkt Outperform rating and provided a target price of $27 on this stock.
Privia Health Group Inc experienced fluctuations in its stock price throughout the past year between $15.92 and $24.35. Currently, Wall Street analysts expect the stock to reach $33.82 within the next 12 months. Privia Health Group Inc [NASDAQ: PRVA] shares were valued at $17.97 at the most recent close of the market. An investor can expect a potential return of 88.2% based on the average PRVA price forecast.
Analyzing the PRVA fundamentals
Trailing Twelve Months sales for Privia Health Group Inc [NASDAQ:PRVA] were 1.70B which represents 2.17% growth. Gross Profit Margin for this corporation currently stands at 0.09% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.60 points at the first support level, and at 17.24 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.18, and for the 2nd resistance point, it is at 18.39.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Privia Health Group Inc [NASDAQ:PRVA] is 1.81. As well, the Quick Ratio is 1.81, while the Cash Ratio is 0.9. Considering the valuation of this stock, the price to sales ratio is 1.27, the price to book ratio is 3.61 and price to earnings (TTM) ratio is 150.50.
Transactions by insiders
Recent insider trading involved Mehrotra Parth, Chief Executive Officer, that happened on Sep 10 ’24 when 0.14 million shares were sold. Officer, Mehrotra Parth completed a deal on Sep 10 ’24 to buy 0.14 million shares. Meanwhile, Director Boehler Adam bought 364.0 shares on Jun 11 ’24.
